| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |